Search results
PFE, BNTX and MRNA Omicron Boosters Get Positive CHMP Opinion
Zacks via Yahoo Finance· 2 years agoIt has been a good week for leading COVID-19 vaccine makers, Pfizer PFE /BioNTech BNTX and Moderna...
Omicron: Experts want more data to guide US targeting of fall boosters
Yahoo Finance via AOL· 2 years agoThe U.S. Food and Drug Administration wants COVID-19 manufacturers to target the latest BA.4/BA.5...
Another updated COVID vaccine could be available in the fall. Here’s what we know
Sacramento Bee via Yahoo News· 1 year agoCOVID-19 vaccines are due for another update and new formulas could be available in the U.S. by the...
The Zacks Analyst Blog Highlights Sanofi, Merck, Novartis, Pfizer and J&J
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – July 1, 2022 – Zacks.com announces the list of stocks featured...
COVID-19 weekly update: Cases increase by 8,661, with 67 new known deaths
AZCentral | The Arizona Republic via Yahoo News· 2 years agoReported COVID-19 cases in Arizona were similar to last week's numbers and the percentage of tests...
A new COVID variant is dominant in the US: What are its symptoms?
TODAY via Yahoo News· 3 hours agoThe new "FLiRT" COVID-19 variants, including KP.3 and KP.2, are spreading in the United States. Will...
The Zacks Analyst Blog Highlights Pfizer, BioNTech, Moderna and Novavax
Zacks via Yahoo Finance· 9 months agoFor Immediate Release Chicago, IL – September 13, 2023 – Zacks.com announces the list of stocks...
Biotech Stock Roundup: BMY's Study Update, INCY's Drug Label Expansion, MRNA News
Zacks via Yahoo Finance· 2 years agoDrug approvals and other regulatory updates are in focus in the biotech sector. COVID-19 vaccine...
Pfizer (PFE) & BioNTech Get CHMP Nod for Updated Covid-19 Jab
Zacks via Yahoo Finance· 10 months agoPfizer PFE and partner BioNTech BNTX announced that the Committee for Medicinal Products for Human...
Biotech Stock Roundup: NERV, RLMD Down on Updates, MRNA, NVAX's News & More
Zacks via Yahoo Finance· 2 years agoIt was a busy week for the volatile biotech sector, with important regulatory and pipeline updates...